Latest News

Juvenescence Announces Appointment of David Ellam as Chief Financial Officer

TORTOLA, British Virgin Islands–(BUSINESS WIRE)–Juvenescence, a life sciences company developing therapeutics and technologies to treat diseases of ageing and increase human longevity, announces that David Ellam has joined its Executive Management Team as Chief Financial Officer. David has almost 20 years of experience within life science companies. He has previously occupied several senior finance roles within both US & UK publicly owned life science companies, most recently as CFO at Si

Source link

Related posts

STAT Plus: Archived: A chat to discuss Amazon’s pivot into health care


Medical News Today: How to remove a tan at home


Mars Helicopter With High-Resolution Color Imager Scheduled Launch Revealed


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy